GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Purchase Of Business

KNBIF (Kane Biotech) Purchase Of Business : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Kane Biotech Purchase Of Business?

Kane Biotech's purchase of business for the three months ended in Sep. 2024 was $0.00 Mil. It means Kane Biotech spent $0.00 Mil on purchasing business. Kane Biotech's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), Kane Biotech spent the same money on purchasing business in Sep. 2024 ($0.00 Mil).

Kane Biotech Purchase Of Business Historical Data

The historical data trend for Kane Biotech's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Purchase Of Business Chart

Kane Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kane Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kane Biotech Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Purchase Of Business
Comparable Companies
TSXV:RKV XCNQ:BIOV XCNQ:BETR TSX:APS XCNQ:PREV TSXV:SBM TSXV:CYTO XCNQ:GLOW TSX:RVX TSX:CSCI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
KNE:Canada
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Website
https://www.kanebiotech.com
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.